Korea's Ildong Pharmaceutical Wins License To Sell Shionogi's IPF Drug In Korea
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's Ildong Pharmaceutical Co., Ltd. said it plans to launch Shionogi & Co., Ltd.'s idiopathic pulmonary fibrosis product Pirespa (pirfenidone) in Korea in the first half of 2012 under an in-licensing deal signed July 11